Sanofi India Ltd vs Veerhealth Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Sanofi India Ltd is ₹ 3396 as of 06 May 15:30 . The P/E Ratio of Sanofi India Ltd is 30.8 as of December 2023 .The P/E Ratio of Veerhealth Care Ltd is 0 as of December 2023 . The Market Cap of Sanofi India Ltd is ₹ 18578 crore as of December 2023 .The Market Cap of Veerhealth Care Ltd is ₹ 0 crore as of December 2023 . The Revenue of Sanofi India Ltd is ₹ 578.9 crore as of Jun '24 .The Revenue of Veerhealth Care Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Sanofi India Ltd is ₹ 178.5 crore as of Jun '24 .The EBITDA of Veerhealth Care Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Sanofi India Ltd is ₹ 136.6 crore as of Jun '24 .The Net Profit of Veerhealth Care Ltd is ₹ 0 crore as of Jun '24 . The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% The dividend payout of Veerhealth Care Ltd changed from 0 % to 0 % over 10 quarters. This represents a CAGR of 0.0% .

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.

About Veerhealth Care Ltd

Veerhealth Care Limited was originally incorporated on 10 July, 1992 as Niyati Leasing Limited to start business in Investment and Finance.
The main objects of the Company in 1998 got changed and accordingly the name was changed from Niyati Leasing Limited to Niyati Industries Limited and from Niyati Industries Limited to Veerhealth Care Limited in May, 2013. Initially in 2010, the Company was engaged into dealing and trading of shares, securities, debentures, and other investments.
It wanted to start business in the field of infrastructure.
Later on, the Company through the Main Objects, diversify the business activities to Pharma sector in 2013.
Apart from Tablet, Syrup, Ointment, Powder, it also started manufacturing in the Oil, Shampoo, Ointment and Toothpaste Division in year 2015-16.

FAQs for the comparison of Sanofi India Ltd and Veerhealth Care Ltd

Which company has a larger market capitalization, Sanofi India Ltd or Veerhealth Care Ltd?

Market cap of Sanofi India Ltd is 8,111 Cr while Market cap of Veerhealth Care Ltd is 42 Cr

What are the key factors driving the stock performance of Sanofi India Ltd and Veerhealth Care Ltd?

The stock performance of Sanofi India Ltd and Veerhealth Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi India Ltd and Veerhealth Care Ltd?

As of May 6, 2026, the Sanofi India Ltd stock price is INR ₹3522.25. On the other hand, Veerhealth Care Ltd stock price is INR ₹21.14.

How do dividend payouts of Sanofi India Ltd and Veerhealth Care Ltd compare?

To compare the dividend payouts of Sanofi India Ltd and Veerhealth Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.